Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
03/2011
03/24/2011US20110070163 Cancer cell migration and cancer cell invasion inhibitor
03/24/2011US20110070155 Anti-CD74 Immunoconjugates and Methods
03/23/2011EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins
03/23/2011EP2298736A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/23/2011EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
03/23/2011EP2297184A1 Solubilization of proteins in reverse micelles by extraction from a solid support
03/22/2011US7910704 Human p53 splice variant displaying differential transcriptional activity
03/22/2011US7910690 High density fibrous polymers suitable for implant
03/22/2011US7910322 Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors
03/22/2011US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
03/22/2011CA2480273C Ph-sensitive polymer
03/17/2011WO2011030682A1 Construct coated with virus coat-constituting protein and method for producing same
03/17/2011US20110065178 Dendritic cell potentiation
03/17/2011CA2809819A1 Extracellular targeted drug conjugates
03/16/2011EP2295407A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/16/2011EP2295064A1 Monoclonal antibody therapy for pancreas cancer
03/15/2011US7906627 Chimeric human sweet-umami and umami-sweet taste receptors
03/15/2011US7906484 Complex for transferring an anionic substance into a cell
03/15/2011US7906328 Cell lines that express hetero oligomeric taste receptors
03/15/2011US7906277 Compound and methods for diagnosis of tuberculosis
03/15/2011US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
03/10/2011WO2011026351A1 A cyanovirin n mutant, modified derivative and uses thereof
03/10/2011US20110059121 Compositions and methods for the prevention and treatment of autoimmune conditions
03/09/2011EP2292802A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
03/09/2011EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor
03/09/2011EP1315513B1 "pseudo"-native chemical ligation
03/08/2011US7902488 Microwave-assisted peptide synthesis
03/08/2011US7902341 Methods and compositions for modulating somatolactogenic functions
03/08/2011US7902338 Anti-CD19 antibodies
03/08/2011US7902337 Isolated soybean cyst nematode and soybean sudden death syndrome polypeptides
03/08/2011US7902329 Oligopeptide tyrosinase inhibitors and uses thereof
03/08/2011US7902328 Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
03/08/2011US7901943 Materials and methods for controlling isotope effects during fractionation of analytes
03/08/2011US7901894 Kinase inhibitors
03/08/2011CA2240516C Novel tyrosine kinase receptors and ligands
03/03/2011WO2011025158A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
03/03/2011WO2011022824A1 Rapid multi-component optical protein patterning by photobleaching
03/03/2011WO2010101526A9 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof
03/03/2011US20110054152 Hydroxyalkyl Starch Derivatives
03/03/2011US20110053787 Compositions and Methods of Detecting Post-Stop Peptides
03/03/2011US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents
03/02/2011EP2290109A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
03/02/2011EP2290108A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
03/02/2011EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications
03/02/2011EP1673633B9 Method for detecting feline immunodeficiency virus
03/01/2011US7897730 TRAIL receptor-binding agents and uses of the same
03/01/2011US7897158 Recombinant toxin fragments
03/01/2011CA2326322C Free-form nanofabrication using multi-photon excitation
02/2011
02/24/2011US20110045017 Hiv vaccine for mucosal delivery
02/23/2011EP2286843A2 Compounds for targeting endothelial cells
02/23/2011EP1960427B1 Multimeric fc receptor polypeptides
02/23/2011CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof
02/22/2011US7893204 Attractin/mahogany-like polypeptides
02/22/2011US7893200 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
02/22/2011US7892785 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins
02/22/2011US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors
02/22/2011CA2435877C Prevention of diabetes by administration of gnrh antagonists
02/17/2011US20110040075 Antibody purification by protein a and ion exchange chromatography
02/17/2011US20110039066 Self-cleaning surfaces
02/16/2011EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides
02/16/2011EP2284188A1 Detection of anti-ribosomal P protein antibodies by means of synthetic peptides
02/15/2011US7888493 Nucleic acid encoding protein which has autoinducer inactivation activity; increase disease resistance in plants and animals; capable of efficient inactivation of N-acyl homoserine lactone autoinducers
02/15/2011US7888478 Compositions and methods for the treatment of tumor of hematopoietic origin
02/15/2011US7888475 Interferon alpha and interferon kappa fusion protein
02/15/2011US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same
02/15/2011US7887799 Antibodies to fibroblast growth factor-like polypeptides
02/10/2011WO2011017514A1 Methods for purifying a target protein from one or more impurities in a sample
02/10/2011WO2011017101A2 Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
02/10/2011WO2011015530A2 Process for deposition of thin layers of metal oxides
02/10/2011US20110034737 Water-Soluble Polymer Alkanals
02/10/2011CA2769326A1 Blood coagulation protein conjugates
02/09/2011EP2281194A1 Molecular assebly comprising gold and a linker for detection of (bio) chemical entities
02/09/2011EP2281006A1 Cross-linkers and their uses
02/09/2011CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol
02/08/2011US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease
02/08/2011US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation
02/08/2011US7884053 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
02/08/2011CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
02/08/2011CA2210467C Osteoprotegerin
02/03/2011US20110028879 Aminoglycosides and pregelatinized aminoglycosides covalently conjugated to cotton
02/03/2011US20110027915 Method of producing insoluble carrier particles, insoluble carrier particles, measurement reagent, specimen analyzing tool, and immunoturbidimetric assay
02/02/2011EP2279203A2 Prion epitopes and methods of use thereof
02/02/2011CN101962652A Complex of human glucagon-like peptide (GLP)-1 and preparation method thereof
02/02/2011CN101962410A Cross-linking agent of heparin, collagen material, and growth factor, and preparation method thereof
02/02/2011CN101962409A Conjugate of collagen material and growth factor as well as preparation method thereof
02/01/2011US7881871 Method for designing surfaces
02/01/2011US7879323 Antibodies to fibroblast growth factor-like polypeptides
01/2011
01/27/2011WO2011010964A1 Differentiation of isobaric amino acids and other species
01/27/2011US20110020396 HIV Envelope-CD4 Complexes and Hybrids
01/27/2011US20110020335 Treatment of Cancers Expressing p95 ErbB2
01/27/2011US20110020242 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
01/26/2011EP2276836A1 Surfaces with immobilized enzymes or anti-icing proteins
01/26/2011EP1303186B1 Medicinal uses of mu-opioid receptor agonists
01/26/2011CN101475640B Conjugate, and preparation and use thereof
01/25/2011US7875450 Virus-like particles for the induction of autoantibodies
01/25/2011US7875436 immobilization; solid phase synthesis; kits
01/25/2011CA2424611C Identification of protein binding sites
01/25/2011CA2423068C Acoustic ejection of fluids from a plurality of reservoirs
01/20/2011US20110014272 Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria
01/20/2011US20110014216 Drug Transfer Based on Coenzyme A and Acyl Carrier Protein
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 107